RMD - ResMed - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7611521078
Portable Diagnostics, Sleep Therapy Devices, Cloud-Based Software Applications
ResMed Inc. is a leading medical technology company that specializes in developing, manufacturing, and distributing innovative devices and cloud-based software solutions for the healthcare industry.
The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its Sleep and Respiratory Care segment offers a range of products and solutions for respiratory disorders, including portable diagnostic devices like ApneaLink Air and NightOwl, which measure various health metrics to diagnose and monitor sleep apnea and other respiratory conditions.
In addition to its diagnostic devices, ResMed provides a suite of cloud-based software applications that enable remote monitoring, patient engagement, and therapy management. For instance, its AirView system allows healthcare professionals to remotely monitor patients' device settings, while its myAir application provides personalized support and education to patients with sleep apnea.
ResMed's Software as a Service segment offers a range of out-of-hospital software solutions, including Brightree business management software, MatrixCare care management solutions, HEALTHCAREfirst electronic health record and billing services, and MEDIFOX DAN's software solutions. These solutions cater to various healthcare providers, including home medical equipment (HME) providers, senior living communities, home health and hospice organizations, and accountable care organizations.
The company's software solutions aim to streamline clinical and business operations, improve patient outcomes, and enhance the overall quality of care. By providing a comprehensive suite of products and solutions, ResMed enables healthcare professionals to deliver more efficient, effective, and patient-centered care.
With a strong global presence, ResMed markets its products and solutions through a network of distributors and direct sales force, serving sleep clinics, home healthcare dealers, and hospitals worldwide. Founded in 1989, the company is headquartered in San Diego, California, and has established itself as a leader in the medical technology industry.
Drawdown (Underwater) Chart
RMD Stock Overview
Market Cap in USD | 35,966m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 1995-06-02 |
RMD Stock Ratings
Growth 5y | 48.3 |
Fundamental | 89.9 |
Dividend | 49.0 |
Rel. Performance vs Sector | 1.45 |
Analysts | 3.86/5 |
Fair Price Momentum | 252.72 USD |
Fair Price DCF | 218.41 USD |
RMD Dividends
Dividend Yield 12m | 0.83% |
Yield on Cost 5y | 1.59% |
Dividends CAGR 5y | 3.90% |
Payout Consistency | 100.0% |
RMD Growth Ratios
Growth 12m | 66.06% |
Growth Correlation 12m | 92.8% |
Growth Correlation 3m | 80.2% |
CAGR 5y | 13.86% |
CAGR/Mean DD 5y | 0.72 |
Sharpe Ratio 12m | 1.63 |
Alpha vs SP500 12m | 33.76 |
Beta vs SP500 5y weekly | 0.94 |
ValueRay RSI | 31.26 |
Volatility GJR Garch 1y | 34.01% |
Price / SMA 50 | 0.95% |
Price / SMA 200 | 16.62% |
Current Volume | 749.7k |
Average Volume 20d | 1055.5k |
External Links for RMD Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 10, 2024, the stock is trading at USD 237.04 with a total of 749,689 shares traded.
Over the past week, the price has changed by -0.76%, over one month by -5.02%, over three months by +24.84% and over the past year by +75.72%.
According to ValueRays Forecast Model, RMD ResMed will be worth about 279.7 in October 2025. The stock is currently trading at 237.04. This means that the stock has a potential upside of +17.98%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 226.9 | -4.28 |
Analysts Target Price | 184 | -22.4 |
ValueRay Target Price | 279.7 | 18.0 |